Company Filing History:
4 out of 4 
1 out of 832,912 Years Active: 2003-2016
Title: Harri Savilahti: Innovator in Genetic Engineering
Introduction
Harri Savilahti is a prominent inventor based in Helsinki, Finland. He has made significant contributions to the field of genetic engineering, particularly through his innovative methods and techniques. With a total of 5 patents, Savilahti's work has advanced the understanding and application of transposase variants and gene transfer systems.
Latest Patents
Savilahti's latest patents include a method for producing hyperactive transposase mutants. This invention provides a method for creating a hyperactive MuA transposase variant through specific modifications in the nucleic acid encoding the wild type MuA transposase. The resulting variant exhibits enhanced enzyme activity compared to its wild type counterpart. Another notable patent is a method for delivering nucleic acid into eukaryotic genomes. This invention focuses on utilizing DNA transposition complexes of bacteriophage Mu to facilitate gene transfer into eukaryotic cells, enabling the creation of insertional mutant libraries.
Career Highlights
Throughout his career, Harri Savilahti has worked with various organizations, including Finnzymes Oy. His expertise in genetic engineering has positioned him as a key figure in the development of innovative solutions in the field.
Collaborations
Savilahti has collaborated with notable individuals such as Mikko Frilander and Xiaojuan Meng. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.
Conclusion
Harri Savilahti's contributions to genetic engineering through his patents and collaborations highlight his role as an influential inventor. His innovative methods continue to impact the field and pave the way for future advancements.